Challenges for management of immune thrombocytopenia during COVID-19 pandemic
- PMID: 32619062
- PMCID: PMC7361579
- DOI: 10.1002/jmv.26251
Challenges for management of immune thrombocytopenia during COVID-19 pandemic
Keywords: SARS coronavirus; coronavirus; epidemiology; immune responses; pandemics; plasma cell; virus classification.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures
References
-
- Sahu KK, Siddiqui AD, Cerny J. Managing sickle cell patients with COVID‐19 infection: the need to pool our collective experience. British J Haematol. 2020. https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.16880 - DOI - PMC - PubMed
-
- Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. New Eng J Med. 2020;382(18):1708‐1720. https://www.nejm.org/doi/10.1056/NEJMoa2002032 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
